Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2001

View Archived Issues

Sterix raises funds for R&D programs

Human growth hormone peptide analogue under active development for obesity

Copper/zinc chelator may address underlying cause of Alzheimer's disease

AstraZeneca selects tradename for investigational anticoagulant

Mechanism of blood pressure-lowering effects of PPARgamma agonists studied using GW-1929

BioMarin files application to conduct human trials with topical Vibriolysin

Amgen launches ARANESP in the E.U.

Beneficial effects of insulin sensitizer on lipoprotein abnormalities in db/db mice

Ligand and TAP establish R&D alliance for SARMs

EntreMed and NEI study Panzem in age-related macular degeneration

Efficacy and safety of COL-1621 demonstrated in men with testosterone deficiency

Zycos and Aventis Pasteur extend drug discovery alliance

Medarex and Epicyte to codevelop therapeutic antibodies

New GH receptor antagonist may have a role in the management of colon cancer

Phase I/II trial begins for malignant melanoma vaccine

NicOx and Biolipox to codevelop NO-releasing respiratory therapies

New, orally active PTP1B inhibitor lowers plasma glucose and insulin levels in ob/ob mice

Phase I/II bladder cancer trial shows 59% complete response rate on MCC therapy

International Psoriasis Symposium selected by MedImmune to present phase I results for MEDI-507

Profile of novel SERM indicates potential in both osteoporosis and endometriosis

Inhibitors of proteases such as cathepsin K and methods of use

Oligobenzimidazoles discovered by Aventis to be useful for DNA transfection

Orally active antifungal agents patented by Toagosei

Novel antiallergic agents in the Taisho pipeline

Chemokine antagonists claimed for wide series of conditions in recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...